Investor Presentaiton
Total Addressable Market
LGP's total addressable market is estimated at ~$24bn¹ at maturity
The global medicinal cannabis is experiencing dramatic growth and LGP is one of a few companies world-wide with the
capability to deliver into these new and emerging markets
The following countries have been identified as LGP's current target markets based on regulatory frameworks and
capability to deliver into key distribution networks
Country
Australia
Population
25m
TAM at maturity
Notes
A$1bn
France
65m
A$6bn
Germany
84m
A$8bn
CBD over the counter could increase this estimate
Currently illegal (Government medicinal cannabis trial
underway)
Already a large market
United Kingdom
68m
A$6bn
Denmark
6m
A$1bn
Restricted by condition. CBD legal and widely available
Government extended medicinal cannabis trial
Brazil
213m
A$2bn
Cultivation illegal, but imported oils are permitted
TOTAL
461m
A$24bn
1. Canaccord Genuity Estimates - 12 May 2021 (based on Worldometer)
little
green
pharma
25View entire presentation